Expert calls for harm reduction to address drug overdose crisis

With more than 100,000 drug overdose deaths in the United States in one year, communities need more than ‘just say no’ drug prevention education and abstinence-only addiction treatment to save lives, an expert has warned.

Bioinformatics: Why Life Sciences Must Adopt Open Science

Evan Floden, CEO and co-founder of Seqera Today’s biomedical research can be complex and time-consuming, as researchers grapple with the challenging task of managing and

October 8, 2024

US FDA grants approval for Pfizer’s RSV vaccine

The FDA approved Pfizer’s Abrysvo based on the findings from the Phase III MATISSE clinical trial. Credit: Pfizer. The US Food and Drug Administration (FDA)

August 22, 2023

Novartis adds Indianapolis site to its manufacturing capacity for radioligand drug Pluvicto

Novartis has the go-ahead from the FDA to manufacture its radiopharmaceutical Pluvicto at a new facility in Indianapolis, marking a step toward addressing burgeoning demand.

January 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.